Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.
Shares of Ross Stores, Inc. (NASDAQ: ROST) surged during Friday’s session as the company reported upbeat results for its third quarter and raised FY23 earnings guidance.
Ross Stores reported quarterly earnings of $1.33 per share, surpassing estimates of $1.21, representing a 33% increase over earnings of $1.00 per share from the same period last year. Revenue clocked in at $4.92 billion, above the analyst consensus estimate of $4.82 billion, according to data from Benzinga Pro.
The company raised its full-year 2023 earnings per share outlook from between $5.15 and $5.26 to between $5.30 and $5.36.
Ross Stores shares climbed 8.8% to $130.67 on Friday.
Here are some big stocks recording gains in today’s session.
- The Gap, Inc. (NYSE: GPS) shares jumped 26.9% to $17.35 after the company reported better-than-expected financial results for the third quarter on Thursday.
- Twist Bioscience Corporation (NASDAQ: TWST) surged 20.2% to $22.93 following strong quarterly results.
- Qifu Technology, Inc. (NASDAQ: QFIN) shares rose 14% to $17.66 following third-quarter results.
- GDEV Inc. (NASDAQ: GDEV) climbed 13.2% to $3.00.
- VNET Group, Inc. (NASDAQ: VNET) gained 13% to $2.95.
- Caribou Biosciences, Inc. (NASDAQ: CRBU) surged 12.4% to $5.32.
- Icosavax, Inc. (NASDAQ: ICVX) rose 11.2% to $10.36. Guggenheim initiated coverage on Icosavax with a Buy rating and announced a price target of $28.
- Globant S.A. (NYSE: GLOB) jumped 12.4% to $205.73 following upbeat third-quarter results.
- Brookdale Senior Living Inc. (NYSE: BKD) rose 11.2% to $5.03. RBC Capital upgraded Brookdale Senior Living from Sector Perform to Outperform and raised the price target from $7 to $9.
- Tenet Healthcare Corporation (NYSE: THC) gained 11% to $64.60 after it inked a deal with Novant Health to sell three hospitals and related operations in South Carolina for around $2.4 billion in cash.
- CRISPR Therapeutics AG (NASDAQ: CRSP) gained 8.4% to $64.50. CRISPR Therapeutics recently announced regulatory authorization of the first CRISPR/Cas9 gene-edited therapy.
- Manchester United plc (NYSE: MANU) gained 7.4% to $19.79 following a report suggesting Jim Ratcliffe's Ineos Sports is in talks to buy a 25% stake in the club for $33 per share.
- Abercrombie & Fitch Co. (NYSE: ANF) gained 7.4% to $74.10.
- The Buckle, Inc. (NYSE: BKE) rose 7.3% to $37.50 following upbeat earnings.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.